Skip to main content
SpringerLink
Log in

PCOS in Adolescence: Diagnostic Dilemmas and Management Considerations

  • Chapter
  • First Online:
Polycystic Ovary Syndrome

  • 2623 Accesses

Abstract

Polycystic ovary syndrome (PCOS) is a difficult diagnosis in adolescents due to overlapping symptoms of puberty. However, signs and symptoms of PCOS arise in the peri-pubertal years; therefore, irregular menses in adolescents should be addressed by thorough evaluation. Establishing the presence of hyperandrogenemia is key to the diagnosis of PCOS in adolescents, although controversy exists about the accuracy and comparability of testosterone testing across laboratories. Insulin resistance is closely linked to the pathophysiologic perpetuation of the condition and is targeted by safe and effective treatment with metformin. Other treatments include oral contraceptive pills and anti-androgens. Given that there are no long-term treatment studies on the effects of different treatment modalities as they apply to obese and non-obese phenotypes of adolescent PCOS, current management is guided by the general therapeutic principles of these drugs, targeting the individual phenotype. More treatment and long-term outcome studies need to be performed for this age group in order to gain a better understanding of the benefits of early intervention in terms of medical sequelae.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond). 2008;32(7):1035–41. PubMed PMID: 18458678. eng.

    Article  CAS  Google Scholar 

  2. Ibanez L, de Zegher F. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. J Clin Endocrinol Metab. 2005;90(1):39–43. PubMed PMID: 15483105.

    Article  PubMed  CAS  Google Scholar 

  3. Ibanez L, Ferrer A, Ong K, Amin R, Dunger D, de Zegher F. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr. 2004;144(1):23–9. PubMed PMID: 14722514. eng.

    Article  PubMed  Google Scholar 

  4. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F. Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity. J Pediatr. 2010;156(1):98–102.e1. PubMed PMID: 19772969.

    Article  PubMed  CAS  Google Scholar 

  5. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J Clin Endocrinol Metab. 2011;96(8):E1262–7. PubMed PMID: 21632811.

    Article  PubMed  CAS  Google Scholar 

  6. Ibanez L, Valls C, Marcos MV, Ong K, Dunger DB, De Zegher F. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab. 2004;89(9):4331–7. PubMed PMID: 15356029.

    Article  PubMed  CAS  Google Scholar 

  7. Bonny AE, Appelbaum H, Connor EL, Cromer B, DiVasta A, Gomez-Lobo V, et al. Clinical variability in approaches to polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2012;25(4):259–61. PubMed PMID: 22840936.

    Article  PubMed  Google Scholar 

  8. Johnstone EB, Rosen MP, Neril R, Trevithick D, Sternfeld B, Murphy R, et al. The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab. 2010;95(11):4965–72. PubMed PMID: 20719841. eng.

    Article  PubMed  CAS  Google Scholar 

  9. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237–45. PubMed PMID: 16940456. eng.

    Article  PubMed  CAS  Google Scholar 

  10. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38.e25. PubMed PMID: 22153789.

    Article  PubMed  Google Scholar 

  11. Rosner W, Vesper H. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab. 2010;95(10):4542–8. PubMed PMID: 20926540. eng.

    Article  PubMed  CAS  Google Scholar 

  12. Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203(3):201.e1–5. PubMed PMID: 20435290. eng.

    Article  Google Scholar 

  13. Apter D, Vihko R. Premenarcheal endocrine changes in relation to age at menarche. Clin Endocrinol. 1985;22(6):753–60. PubMed PMID: 3160508.

    Article  CAS  Google Scholar 

  14. Hart R, Doherty DA, Mori T, Huang RC, Norman RJ, Franks S, et al. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertil Steril. 2011;95(7):2347–53. 53.e1. PubMed PMID: 21450287.

    Article  PubMed  Google Scholar 

  15. Wiksten-Almstromer M, Hirschberg AL, Hagenfeldt K. Prospective follow-up of menstrual disorders in adolescence and prognostic factors. Acta Obstet Gynecol Scand. 2008;87(11):1162–8. PubMed PMID: 18956264.

    Article  PubMed  Google Scholar 

  16. Pinola P, Lashen H, Bloigu A, Puukka K, Ulmanen M, Ruokonen A, et al. Menstrual disorders in adolescence a marker for hyperandrogenaemia and increased metabolic risks in later life Finnish general population-based birth cohort study. Hum Reprod. 2012;27(11):3279–86. PubMed PMID: 22933528.

    Article  PubMed  CAS  Google Scholar 

  17. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod. 2004;19(2):383–92. PubMed PMID: 14747186.

    Article  PubMed  Google Scholar 

  18. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update. 2003;9(6):505–14. PubMed PMID: 14714587.

    Article  PubMed  Google Scholar 

  19. Fulghesu AM, Angioni S, Frau E, Belosi C, Apa R, Mioni R, et al. Ultrasound in polycystic ovary syndrome—the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Hum Reprod. 2007;22(9):2501–8. PubMed PMID: 17635847. eng.

    Article  PubMed  CAS  Google Scholar 

  20. Battaglia C, Battaglia B, Morotti E, Paradisi R, Zanetti I, Meriggiola MC, et al. Two- and three-dimensional sonographic and color Doppler techniques for diagnosis of polycystic ovary syndrome. The stromal/ovarian volume ratio as a new diagnostic criterion. J Ultrasound Med. 2012;31(7):1015–24. PubMed PMID: 22733850.

    PubMed  Google Scholar 

  21. Villa P, Rossodivita A, Sagnella F, Moruzzi MC, Mariano N, Lassandro AP, et al. Ovarian volume and gluco-insulinaemic markers in the diagnosis of PCOS during adolescence. Clin Endocrinol. 2013;78(2):285–90. PubMed PMID: 22724514.

    Article  CAS  Google Scholar 

  22. Chen Y, Yang D, Li L, Chen X. The role of ovarian volume as a diagnostic criterion for Chinese adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2008;21(6):347–50. PubMed PMID: 19064229.

    Article  PubMed  Google Scholar 

  23. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril. 2000;74(1):49–58. PubMed PMID: 10899496.

    Article  PubMed  Google Scholar 

  24. Mortensen M, Rosenfield RL, Littlejohn E. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006;91(10):3786–90. PubMed PMID: 16895960. eng.

    Article  PubMed  CAS  Google Scholar 

  25. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol. 1999;51(6):779–86. PubMed PMID: 10619984.

    Article  CAS  Google Scholar 

  26. Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, Norman RJ, et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod. 2011;26(6):1469–77. PubMed PMID: 21478180.

    Article  PubMed  CAS  Google Scholar 

  27. Sir-Petermann T, Codner E, Perez V, Echiburu B, Maliqueo M, Ladron de Guevara A, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(6):1923–30. PubMed PMID: 19223518. eng.

    Article  PubMed  CAS  Google Scholar 

  28. Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol. 2011;4(2):45–51. PubMed PMID: 22102927, Pubmed Central PMCID: 3218544.

    PubMed  Google Scholar 

  29. Pfeifer SM, Kives S. Polycystic ovary syndrome in the adolescent. Obstet Gynecol Clin North Am. 2009;36(1):129–52. PubMed PMID: 19344852.

    Article  PubMed  Google Scholar 

  30. DeUgarte CM, Woods KS, Bartolucci AA, Azziz R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab. 2006;91(4):1345–50. PubMed PMID: 16449347.

    Article  PubMed  CAS  Google Scholar 

  31. Lucky AW, Biro FM, Daniels SR, Cedars MI, Khoury PR, Morrison JA. The prevalence of upper lip hair in black and white girls during puberty: a new standard. J Pediatr. 2001;138(1):134–6. PubMed PMID: 11148529.

    Article  PubMed  CAS  Google Scholar 

  32. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Endocrine features of polycystic ovary syndrome in a random population sample of 14–16 year old adolescents. Hum Reprod. 1999;14(9):2223–9. PubMed PMID: 10469684.

    Article  PubMed  Google Scholar 

  33. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88. PubMed PMID: 18950759.

    Article  PubMed  Google Scholar 

  34. Hahn S, Kuehnel W, Tan S, Kramer K, Schmidt M, Roesler S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med. 2007;45(2):202–7. PubMed PMID: 17311509.

    Article  PubMed  CAS  Google Scholar 

  35. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92(2):405–13. PubMed PMID: 17090633.

    Article  PubMed  CAS  Google Scholar 

  36. Rachon D. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2012;120(4):205–9. PubMed PMID: 22421986.

    Article  PubMed  CAS  Google Scholar 

  37. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362–74. PubMed PMID: 15175438.

    Article  PubMed  CAS  Google Scholar 

  38. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91(2):492–7. PubMed PMID: 16249280.

    Article  PubMed  CAS  Google Scholar 

  39. Roe AH, Prochaska E, Smith M, Sammel M, Dokras A. Using the Androgen Excess-PCOS Society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J Pediatr. 2013;162(5):937–41.

    Article  PubMed  Google Scholar 

  40. Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(3):1175–80. PubMed PMID: 11238505.

    Article  PubMed  CAS  Google Scholar 

  41. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab. 2001;86(2):517–20. PubMed PMID: 11158002.

    Article  PubMed  CAS  Google Scholar 

  42. Saaresranta T, Polo O. Hormones and breathing. Chest. 2002;122(6):2165–82. PubMed PMID: 12475861.

    Article  PubMed  CAS  Google Scholar 

  43. Gopal M, Duntley S, Uhles M, Attarian H. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med. 2002;3(5):401–4. PubMed PMID: 14592171.

    Article  PubMed  Google Scholar 

  44. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36. PubMed PMID: 15788499.

    Article  PubMed  CAS  Google Scholar 

  45. Subramanian S, Desai A, Joshipura M, Surani S. Practice patterns of screening for sleep apnea in physicians treating PCOS patients. Sleep Breath. 2007;11(4):233–7. PubMed PMID: 17541663.

    Article  PubMed  Google Scholar 

  46. de Sousa G, Schluter B, Buschatz D, Menke T, Trowitzsch E, Andler W, et al. A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents. Sleep Breath. 2010;14(1):33–8. PubMed PMID: 19585163.

    Article  PubMed  Google Scholar 

  47. Nandalike K, Agarwal C, Strauss T, Coupey SM, Isasi CR, Sin S, et al. Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Med. 2012;13(10):1307–12. PubMed PMID: 22921588, Pubmed Central PMCID: 3509263.

    Article  PubMed  Google Scholar 

  48. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia. 2009;52(3):415–24. PubMed PMID: 19130039.

    Article  PubMed  CAS  Google Scholar 

  49. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84(1):165–9. PubMed PMID: 9920077. eng.

    Article  PubMed  CAS  Google Scholar 

  50. Morandi A, Maschio M, Marigliano M, Miraglia Del Giudice E, Moro B, Peverelli P, et al. Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study. Pediatr Obes. 2013. PubMed PMID: 23296488.

    Google Scholar 

  51. Reinehr T, Wiegand S, Siegfried W, Keller KM, Widhalm K, L'Allemand D, et al. Comorbidities in overweight children and adolescents: do we treat them effectively? Int J Obes (Lond). 2013;37(4):493–9. PubMed PMID: 23147116.

    Article  CAS  Google Scholar 

  52. Standards of medical care in diabetes—2011. Diabetes care. 34 Suppl 1:S11–61. PubMed PMID: 21193625. eng.

    Google Scholar 

  53. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346(11):802–10. PubMed PMID: 11893791.

    Article  PubMed  CAS  Google Scholar 

  54. Bekx MT, Connor EC, Allen DB. Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2010;23(1):7–10. PubMed PMID: 19648034.

    Article  PubMed  Google Scholar 

  55. Nur MM, Newman IM, Siqueira LM. Glucose metabolism in overweight Hispanic adolescents with and without polycystic ovary syndrome. Pediatrics. 2009;124(3):e496–502. PubMed PMID: 19706563.

    Article  PubMed  Google Scholar 

  56. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(3):1017–23. PubMed PMID: 11889155. eng.

    Article  PubMed  CAS  Google Scholar 

  57. Bhattacharya SM. Abnormal glucose tolerance in polycystic ovary syndrome. J Obstet Gynaecol Res. 2008;34(2):228–32. PubMed PMID: 18412786.

    Article  PubMed  CAS  Google Scholar 

  58. Flannery CA, Rackow B, Cong X, Duran E, Selen DJ, Burgert TS. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI. Pediatr Diabetes. 2013;14(1):42–9. PubMed PMID: 22925367.

    Article  PubMed  Google Scholar 

  59. Li L, Chen X, He Z, Zhao X, Huang L, Yang D. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents. J Pediatr Adolesc Gynecol. 2012;25(6):390–5. PubMed PMID: 23089573.

    Article  PubMed  Google Scholar 

  60. Ibanez L, Valls C, Ferrer A, Marcos MV, Rodriguez-Hierro F, de Zegher F. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. J Clin Endocrinol Metab. 2001;86(8):3595–8. PubMed PMID: 11502783.

    Article  PubMed  CAS  Google Scholar 

  61. Ibanez L, Diaz M, Sebastiani G, Sanchez-Infantes D, Salvador C, Lopez-Bermejo A, et al. Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin. J Clin Endocrinol Metab. 2011;96(11):3361–6. PubMed PMID: 21865363.

    Article  PubMed  CAS  Google Scholar 

  62. Lass N, Kleber M, Winkel K, Wunsch R, Reinehr T. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab. 2011;96(11):3533–40. PubMed PMID: 21880803.

    Article  PubMed  CAS  Google Scholar 

  63. Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab. 2008;93(11):4299–306. PubMed PMID: 18728175, Pubmed Central PMCID: 2582568.

    Article  PubMed  CAS  Google Scholar 

  64. Geller DH, Pacaud D, Gordon CM, Misra M, of the Therapeutics Committee of the Pediatric Endocrine. State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS). Int J Pediatr Endocrinol. 2011;2011:9. PubMed PMID: 21899727, Pubmed Central PMCID: 3180691.

    Article  PubMed  Google Scholar 

  65. Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome. Contraception. 2010;82(2):139–46. PubMed PMID: 20654754.

    Article  PubMed  CAS  Google Scholar 

  66. Ibanez L, De Zegher F. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity. Hum Reprod. 2004;19(8):1725–7. PubMed PMID: 15229206.

    Article  PubMed  CAS  Google Scholar 

  67. Dunn N. The risk of deep venous thrombosis with oral contraceptives containing drospirenone. BMJ. 2011;342:d2519. PubMed PMID: 21511807.

    Article  PubMed  Google Scholar 

  68. Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case–control study using United States claims data. BMJ. 2011;342:d2151. PubMed PMID: 21511805, Pubmed Central PMCID: 3081040.

    Article  PubMed  Google Scholar 

  69. Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ. 2011;342:d2139. PubMed PMID: 21511804, Pubmed Central PMCID: 3081041.

    Article  PubMed  Google Scholar 

  70. Mastorakos G, Koliopoulos C, Creatsas G. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril. 2002;77(5):919–27. PubMed PMID: 12009344.

    Article  PubMed  Google Scholar 

  71. Mastorakos G, Koliopoulos C, Deligeoroglou E, Diamanti-Kandarakis E, Creatsas G. Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril. 2006;85(2):420–7. PubMed PMID: 16595221.

    Article  PubMed  CAS  Google Scholar 

  72. Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles. Contraception. 2004;69(4):271–8. PubMed PMID: 15033400.

    Article  PubMed  CAS  Google Scholar 

  73. Guido M, Romualdi D, Giuliani M, Suriano R, Selvaggi L, Apa R, et al. Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab. 2004;89(6):2817–23. PubMed PMID: 15181063.

    Article  PubMed  CAS  Google Scholar 

  74. Vrbikova J, Cibula D. Combined oral contraceptives in the treatment of polycystic ovary syndrome. Hum Reprod Update. 2005;11(3):277–91. PubMed PMID: 15790599.

    Article  PubMed  CAS  Google Scholar 

  75. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism. 1994;43(5):647–54. PubMed PMID: 8177055.

    Article  PubMed  CAS  Google Scholar 

  76. Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). J Adolesc Health. 2001;29(3):160–9. PubMed PMID: 11524214.

    Article  PubMed  CAS  Google Scholar 

  77. Arslanian SA, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab. 2002;87(4):1555–9. PubMed PMID: 11932281.

    Article  PubMed  CAS  Google Scholar 

  78. Bridger T, MacDonald S, Baltzer F, Rodd C. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2006;160(3):241–6. PubMed PMID: 16520442.

    Article  PubMed  Google Scholar 

  79. Ibanez L, Potau N, Ferrer A, Rodriguez-Hierro F, Marcos MV, De Zegher F. Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism. J Clin Endocrinol Metab. 2002;87(12):5702–5. PubMed PMID: 12466374.

    Article  PubMed  CAS  Google Scholar 

  80. Ibanez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche–normal variant or forerunner of adult disease? Endocr Rev. 2000;21(6):671–96. PubMed PMID: 11133068.

    Article  PubMed  CAS  Google Scholar 

  81. Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F. Early metformin therapy to delay menarche and augment height in girls with precocious pubarche. Fertil Steril. 2011;95(2):727–30. PubMed PMID: 20883985.

    Article  PubMed  CAS  Google Scholar 

  82. Burgert TS, Duran EJ, Goldberg-Gell R, Dziura J, Yeckel CW, Katz S, et al. Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance. Pediatr Diabetes. 2008;9(6):567–76. PubMed PMID: 18761646.

    Article  PubMed  CAS  Google Scholar 

  83. Bouza C, Lopez-Cuadrado T, Gutierrez-Torres LF, Amate J. Efficacy and safety of metformin for treatment of overweight and obesity in adolescents: an updated systematic review and meta-analysis. Obes Facts. 2012;5(5):753–65. PubMed PMID: 23108505.

    Article  PubMed  CAS  Google Scholar 

  84. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care. 2000;23(9):1227–31. PubMed PMID: 10977010.

    Article  PubMed  CAS  Google Scholar 

  85. Alemzadeh R, Kichler J, Calhoun M. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Eur J Endocrinol. 2010;162(6):1093–9. PubMed PMID: 20371657.

    Article  PubMed  CAS  Google Scholar 

  86. Ibanez L, Valls C, Cabre S, De Zegher F. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. J Clin Endocrinol Metab. 2004;89(9):4716–20. PubMed PMID: 15356085.

    Article  PubMed  CAS  Google Scholar 

  87. Ibanez L, de Zegher F. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women. Fertil Steril. 2006;86 Suppl 1:S24–5. PubMed PMID: 16798281.

    Article  PubMed  CAS  Google Scholar 

  88. de Zegher F, Ibanez L. Low-dose flutamide for women with androgen excess: anti-androgenic efficacy and hepatic safety. J Endocrinol Invest. 2009;32(1):83–4. PubMed PMID: 19337022.

    PubMed  Google Scholar 

  89. Paradisi R, Fabbri R, Porcu E, Battaglia C, Seracchioli R, Venturoli S. Retrospective, observational study on the effects and tolerability of flutamide in a large population of patients with acne and seborrhea over a 15-year period. Gynecol Endocrinol. 2011;27(10):823–9. PubMed PMID: 21117864.

    Article  PubMed  CAS  Google Scholar 

  90. Stripp B, Taylor AA, Bartter FC, Gillette JR, Loriaux DL, Easley R, et al. Effect of spironolactone on sex hormones in man. J Clin Endocrinol Metab. 1975;41(4):777–81. PubMed PMID: 1176584.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Yale New Haven Hospital, 333 Cedar Street, New Haven, CT, 06520, USA

    Tania S. Burgert M.D.

Authors
  1. Tania S. Burgert M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tania S. Burgert M.D. .

Editor information

Editors and Affiliations

  1. Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine Program for Polycystic Ovary Syndrome Yale Reproductive Endocrinology, New Haven, Connecticut, USA

    Lubna Pal

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Burgert, T.S. (2014). PCOS in Adolescence: Diagnostic Dilemmas and Management Considerations. In: Pal, L. (eds) Polycystic Ovary Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8394-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8394-6_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8393-9

  • Online ISBN: 978-1-4614-8394-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation